@article{07b2443c8017402aa388ac0a4ad654e9,
title = "Phase I Safety and Pharmacokinetic (PK) Study of Veliparib in Combination With Whole Brain Radiation Therapy (WBRT) in Patients (pts) With Brain Metastases",
author = "M.P. Mehta and W.J. Curran and D. Wang and F. Wang and L. Kleinberg and A. Brade and N. Mostafa and J. Qian and T. Leahy and B. Desai",
note = "Author Disclosure: M.P. Mehta: A. Employee; Pharmacyclics. F. Honoraria; Merck, Grace, MDM, Prime Onc, Strategic, Edge, WebMD. G. Consultant; Bayers, Elekta, Novartis, Quark, Tomotherapy, Vertex, BMS, USOnc. K. Stock; Pharmacyclics, Colby, Accuray, Procertus, Stemina. W.J. Curran: E. Research Grant; Abbott. G. Consultant; BMS. D. Wang: None. F. Wang: None. L.",
year = "2012",
month = jan,
day = "11",
doi = "10.1016/j.ijrobp.2012.07.702",
language = "American English",
volume = "84",
journal = "International Journal of Radiation Oncology Biology Physics",
}